WASHINGTON – Eccentric exercise in the form of downhill walking is a promising new means of reducing elevated liver enzyme levels in overweight and obese sedentary individuals.
This finding...
The ergosterol-synthesis inhibitor posaconazole proved ineffective at eliminating Trypanosoma cruzi DNA from the blood of patients with chronic Chagas’ disease, according to a report published...
Joint hypermobility syndrome is significantly associated with gastrointestinal symptoms, say researchers who found the undiagnosed condition in one-third of unselected patients attending a...
CHICAGO – The investigational "3D" combination of oral antiviral drugs achieved a cure rate that was nothing short of sensational in the phase III PEARL-II trial involving noncirrhotic...
CHICAGO – Oral proton pump inhibitor therapy on the medical ward following endoscopic treatment of patients with a bleeding ulcer is equally effective as the current guideline-recommended practice of...
CHICAGO – Hypothyroid patients who need either at least 125 mcg or 1.5 mcg/kg of levothyroxine per day in order to remain euthyroid should routinely be tested for celiac disease, Dr. Richard S....
CHICAGO – German investigators reported on their experience using the disposable Endocuff device in a prospective, randomized two-center trial involving 498 patients undergoing colonoscopy. The...
CHICAGO – A first-in-class oral drug targeting diarrhea-predominant irritable bowel syndrome achieved its primary and secondary endpoints in a pair of large phase III trials presented at the annual...
CHICAGO – Larazotide acetate, a first-in-class oral medication developed specifically to treat celiac disease, reduced both gastrointestinal and non-GI symptoms in patients who were symptomatic...
CHICAGO – Prucalopride, a high-affinity serotonin 5-hydroxytryptamine4 receptor agonist, proved effective for the treatment of severe chronic constipation in men in a phase III clinical trial.
In...